Creating a Global Company
US Business at a glance
9th Largest Pharma Company in the US Generics Market
*
Dermatology Segment
.
Ranked 2nd by prescriptions## in the US dermatology market
SUN
PHARMA
Comprehensive Portfolio**
.
Wide basket of 600 ANDAs & 66 NDAs filed and 512 ANDAS & 53
NDAS approved across multiple therapies
Robust Pipeline**
.
• 88 ANDAS & 13 NDAs pending approval with USFDA
Market Presence
Flexible Manufacturing
Dosage Forms
**All data as of 31-Dec-2021
• Presence in branded, generics & OTC segments
• Integrated manufacturer with flexibility for manufacturing
onshore/ offshore
• Liquids, Creams, Ointments, Gels, Sprays, Injectable, Tablets,
Capsules, Drug-Device combination
* Source: IQVIA data for 12 months ended Dec 2021
## Source: IQVIA data for 12 months ended Dec 2021
19View entire presentation